DAE HWA Pharmaceutical Co. Ltd (067080) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.020x

Based on the latest financial reports, DAE HWA Pharmaceutical Co. Ltd (067080) has a cash flow conversion efficiency ratio of -0.020x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.72 Billion ≈ $-1.16 Million USD) by net assets (₩85.72 Billion ≈ $58.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DAE HWA Pharmaceutical Co. Ltd market capitalisation for the company's overall valuation and market capitalisation.

DAE HWA Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how DAE HWA Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

DAE HWA Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DAE HWA Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of DAE HWA Pharmaceutical Co. Ltd to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Invesco Trust For Inv Grade NY Munis NYSE:VTN	0.022x
Wam Alternative Assets Ltd AU:WMA	-0.150x
Rajthanee Hospital Public Company Limited BK:RJH	0.088x
RF Acquisition Corp III Ordinary Shares NASDAQ:RFAM	0.000x
Wheels Up Experience Inc NYSE:UP	0.214x
Friedman Industries Inc. Common Stock NYSE MKT:FRD	0.003x
JTC Inc KQ:950170	0.048x
Wellcall Holdings Bhd KLSE:7231	0.095x

Annual Cash Flow Conversion Efficiency for DAE HWA Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. View 067080 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩79.14 Billion ≈ $53.63 Million	₩5.43 Billion ≈ $3.68 Million	0.069x	-19.40%
2024-12-31	₩72.00 Billion ≈ $48.79 Million	₩6.13 Billion ≈ $4.15 Million	0.085x	+1155.66%
2023-12-31	₩73.23 Billion ≈ $49.63 Million	₩-590.27 Million ≈ $-400.02K	-0.008x	-107.81%
2022-12-31	₩77.99 Billion ≈ $52.85 Million	₩8.05 Billion ≈ $5.45 Million	0.103x	-21.32%
2021-12-31	₩79.67 Billion ≈ $53.99 Million	₩10.45 Billion ≈ $7.08 Million	0.131x	+270.58%
2020-12-31	₩81.98 Billion ≈ $55.56 Million	₩2.90 Billion ≈ $1.97 Million	0.035x	+6935.37%
2019-12-31	₩79.35 Billion ≈ $53.77 Million	₩-41.07 Million ≈ $-27.83K	-0.001x	-100.38%
2018-12-31	₩76.88 Billion ≈ $52.10 Million	₩10.49 Billion ≈ $7.11 Million	0.136x	-4.30%
2017-12-31	₩76.75 Billion ≈ $52.02 Million	₩10.94 Billion ≈ $7.42 Million	0.143x	+7.31%
2016-12-31	₩66.15 Billion ≈ $44.83 Million	₩8.79 Billion ≈ $5.96 Million	0.133x	+233.71%
2015-12-31	₩61.06 Billion ≈ $41.38 Million	₩2.43 Billion ≈ $1.65 Million	0.040x	-62.31%
2014-12-31	₩58.51 Billion ≈ $39.65 Million	₩6.18 Billion ≈ $4.19 Million	0.106x	-51.73%
2013-12-31	₩62.03 Billion ≈ $42.04 Million	₩13.57 Billion ≈ $9.20 Million	0.219x	+132.79%
2012-12-31	₩61.39 Billion ≈ $41.60 Million	₩5.77 Billion ≈ $3.91 Million	0.094x	+56.14%
2011-12-31	₩56.99 Billion ≈ $38.62 Million	₩3.43 Billion ≈ $2.32 Million	0.060x	--

About DAE HWA Pharmaceutical Co. Ltd

KQ:067080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$138.91 Million

₩204.97 Billion KRW

Market Cap Rank

#18035 Global

#779 in Korea

Share Price

₩11450.00

Change (1 day)

+3.90%

52-Week Range

₩7870.00 - ₩23300.00

All Time High

₩45034.77